Gallagher Neil has filed 11 insider transactions across 3 companies since April 2023.
Most recent transaction: a grant/award of 50000 shares of Foghorn Therapeutics Inc. ($FHTX) on May 01, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Foghorn Therapeutics Inc. | $FHTX | Gallagher Neil | Not found | A | Stock Options (Right to buy) | 50000 | $4.16 | 50,000.0000 | 54,899,432 | 9999.99% | 0.09% |
| Feb. 10, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Gallagher Neil | President, Head of R&D | S | Common Stock | 4618 | $15.50 | 85,095.0000 | 0 | 5.15% | 0.00% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Gallagher Neil | President, Head of R&D | A | Stock Options (Right to buy) | 110500 | $14.65 | 110,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Gallagher Neil | President, Head of R&D | A | Common Stock | 23400 | $0.00 | 89,713.0000 | 0 | 35.29% | 0.00% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Gallagher Neil | President, Head of R&D | A | Common Stock | 18500 | $0.00 | 66,313.0000 | 0 | 38.69% | 0.00% |
| Dec. 10, 2024 | Zymeworks Inc. | $ZYME | Gallagher Neil | Not found | A | Stock Option (Right to Buy) | 31000 | $0.00 | 31,000.0000 | 76,266,177 | 9999.99% | 0.04% |
| April 2, 2024 | Zymeworks Inc. | $ZYME | Gallagher Neil | Not found | A | Stock Option (Right to Buy) | 74000 | $0.00 | 74,000.0000 | 68,863,010 | 9999.99% | 0.11% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Gallagher Neil | President, Head of R&D | A | Common Stock | 34688 | $0.00 | 34,688.0000 | 0 | 9999.99% | 0.00% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Gallagher Neil | President, Head of R&D | A | Common Stock | 13125 | $0.00 | 47,813.0000 | 0 | 37.84% | 0.00% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Gallagher Neil | President, Head of R&D | A | Stock Options (Right to buy) | 69375 | $22.28 | 69,375.0000 | 0 | 9999.99% | 0.00% |
| April 10, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Gallagher Neil | President, Head of R&D | A | Stock Options (Right to buy) | 250000 | $19.35 | 250,000.0000 | 0 | 9999.99% | 0.00% |